Publications by authors named "Luciano Frontini"

Claim this Profile
C
Cross-sectional study to develop and describe psychometric characteristics of a patient-reported instrument (PROFFIT) for measuring financial toxicity of cancer within a public healthcare system.
Silvia Riva, Laura Arenare, Massimo Di Maio, Fabio Efficace, Vincenzo Montesarchio, Luciano Frontini

BMJ Open· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A qualitative analysis and development of a conceptual model assessing financial toxicity in cancer patients accessing the universal healthcare system.
Silvia Riva, Fabio Efficace, Massimo Di Maio, Jane Bryce, Laura Del Campo, Luciano Frontini

Support Care Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy.
Annamaria Ruzzo, Francesco Graziano, Francesca Galli, Fabio Galli, Eliana Rulli, Luciano Frontini

Sci Rep· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: a protocol.
Silvia Riva, Jane Bryce, Francesco De Lorenzo, Laura Del Campo, Massimo Di Maio, Luciano Frontini

BMJ Open· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy.
Annamaria Ruzzo, Francesco Graziano, Francesca Galli, Fabio Galli, Eliana Rulli, Luciano Frontini

Sci Rep· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time required to start multicentre clinical trials within the Italian Medicine Agency programme of support for independent research.
Gianfranco De Feo, Luciano Frontini, Silvia Rota, Antonio Pepe, Simona Signoriello

J Med Ethics· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients.
Annamaria Ruzzo, Francesco Graziano, Fabio Galli, Elisa Giacomini, Irene Floriani, Luciano Frontini

Sci Rep· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weekly docetaxel vs. docetaxel-based combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer patients. The DISTAL-2 randomized trial.
Vittorio Gebbia, Cesare Gridelli, Claudio Verusio, Luciano Frontini, Enrico Aitini

Lung Cancer· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and clinical implications of venous thromboembolism in advanced colorectal cancer patients: the 'GISCAD-alternating schedule' study findings.
Mario Mandalà, Sandro Barni, Irene Floriani, Luciano Isa, Giuseppe Fornarini, Luciano Frontini

Eur J Cancer· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The dilemma of first-line chemotherapy in advanced non-small-cell lung cancer: are third-generation drugs all the same?].
Francesco Grossi, Filippo de Marinis, Luciano Frontini, Cesare Gridelli

Tumori· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
Stefano Cascinu, Roberto Labianca, Carlo Barone, Armando Santoro, Carlo Carnaghi, Luciano Frontini

J Natl Cancer Inst· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weekly paclitaxel, 5-fluorouracil and folinic acid with granulocyte colony-stimulating factor support in metastatic breast cancer patients: a phase II study.
Cecilia Nistico, Emilio Bria, Biagio Agostara, Sandro Barni, Elvira Colella, Luciano Frontini

Anticancer Drugs· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study.
Paolo Maione, Francesco Perrone, Ciro Gallo, Luigi Manzione, FrancoVito Piantedosi, Luciano Frontini

J Clin Oncol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weekly docetaxel in pretreated metastatic breast cancer patients: a phase I-II study.
Cecilia Nisticò, Francesco Cognetti, Luciano Frontini, Sandro Barni, Gianluigi Ferretti

Oncology· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials.
Massimo Di Maio, Cesare Gridelli, Ciro Gallo, Frances Shepherd, Franco Vito Piantedosi, Luciano Frontini

Lancet Oncol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group.
Cesare Gridelli, Ciro Gallo, Frances A Shepherd, Alfonso Illiano, Francovito Piantedosi, Luciano Frontini

J Clin Oncol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial.
Cesare Gridelli, Francesco Perrone, Ciro Gallo, Silvio Cigolari, Antonio Rossi, Luciano Frontini

J Natl Cancer Inst· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An interesting antitumor drug in the elderly patients over the age of 70: weekly docetaxel.
Luciano Frontini

Tumori· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis